NCT04360343 Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04338204 Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden Status RECRUITING Phase N/A
NCT04331639 High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy Status RECRUITING Phase N/A
NCT04329481 The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients Status UNKNOWN Phase NA
NCT04314375 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis Status RECRUITING Phase PHASE4
NCT04312113 Angiographic Delivery of AD-MSC for Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04309058 Observation of the Effect of Vitamin D Supplementation on Chronic Course of Patients With Ulcerative Colitis Based on Vitamin D Receptor Fok I Gene Polymorphism Status UNKNOWN Phase EARLY_PHASE1
NCT04303260 Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT04290156 The Effect of Joint Transition Visits on Quality of Life in Inflammatory Bowel Diseases (TRANS-IBD) Status UNKNOWN Phase NA
NCT04277546 Open-label Extension Study of Brazikumab in Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT04276649 A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis Status COMPLETED Phase N/A
NCT04259060 Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remission Status WITHDRAWN Phase PHASE2
NCT04257084 Surveillance in Ulcerative Colitis: Narrow Band Image Versus Chromoendoscopy for High-risk Groups Status UNKNOWN Phase NA
NCT04239521 The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata Status COMPLETED Phase N/A
NCT04231110 Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis Status COMPLETED Phase PHASE4